VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹54 Cr | ₹57 Cr | ₹48 Cr | ₹54 Cr | ₹58 Cr |
What is the latest Total Current Liabilities ratio of VIMTA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹48 Cr |
| Mar2021 | ₹54 Cr |
| Mar2020 | ₹58 Cr |
How is Total Current Liabilities of VIMTA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹54 Cr | -5.60 | |
| Mar2023 | ₹57 Cr | 19.95 | |
| Mar2022 | ₹48 Cr | -11.43 | |
| Mar2021 | ₹54 Cr | -6.34 | |
| Mar2020 | ₹58 Cr | - | |
Compare Total Current Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,687.6 Cr | 0.9% | -1.6% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 0.9% |
-1.6% |
24.4% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses